SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-16-521896
Filing Date
2016-03-30
Accepted
2016-03-29 20:53:06
Documents
2
Group Members
ANSBERT GADICKEDENNIS HENNERKURT WHEELERLUKE EVNINMICHAEL STEINMETZMPM ASSET MANAGEMENT INVESTORS 2004 BVIII LLCMPM BIOVENTURES III GMBH & CO. BETEILIGUNGS KGMPM BIOVENTURES III GP, L.P.MPM BIOVENTURES III LLCMPM BIOVENTURES III PARALLEL FUND, L.P.MPM BIO

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d171693dsc13da.htm SC 13D/A 255989
2 EX-99.1 d171693dex991.htm EX-99.1 18061
  Complete submission text file 0001193125-16-521896.txt   276413
Mailing Address THE JOHN HANCOCK TOWER 200 CLARENDON STREET, 5TH FLOOR BOSTON MA 02116
Business Address THE JOHN HANCOCK TOWER 200 CLARENDON STREET, 5TH FLOOR BOSTON MA 02116 617 425 9200
MPM BIOVENTURES III L.P. (Filed by) CIK: 0001173408 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address ONE PARK PLACE, SUITE 450 ANNAPOLIS MD 21401
Business Address ONE PARK PLACE, SUITE 450 ANNAPOLIS MD 21401 410 269 2600
PHARMATHENE, INC (Subject) CIK: 0001326190 (see all company filings)

IRS No.: 202726770 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-80900 | Film No.: 161536825
SIC: 2834 Pharmaceutical Preparations